ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 94 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,377 | -38.4% | 320,184 | -25.2% | 0.00% | – |
| Q2 2023 | $1,066,400 | +34.5% | 428,273 | +33.9% | 0.00% | – |
| Q4 2022 | $793,086 | +12.2% | 319,793 | -0.1% | 0.00% | – |
| Q3 2022 | $707,000 | -18.6% | 320,003 | -2.6% | 0.00% | – |
| Q2 2022 | $869,000 | -8.8% | 328,462 | +3.1% | 0.00% | – |
| Q1 2022 | $953,000 | +3.5% | 318,580 | +34.5% | 0.00% | – |
| Q4 2021 | $921,000 | +1.2% | 236,858 | +11.4% | 0.00% | – |
| Q3 2021 | $910,000 | +14.3% | 212,561 | -15.7% | 0.00% | – |
| Q2 2021 | $796,000 | -9.9% | 252,041 | -6.1% | 0.00% | -100.0% |
| Q1 2021 | $883,000 | -45.6% | 268,388 | -28.5% | 0.00% | 0.0% |
| Q4 2020 | $1,622,000 | +30.2% | 375,513 | -7.5% | 0.00% | 0.0% |
| Q3 2020 | $1,246,000 | +43.7% | 406,015 | -12.9% | 0.00% | 0.0% |
| Q2 2020 | $867,000 | +53.2% | 465,966 | -17.6% | 0.00% | 0.0% |
| Q1 2020 | $566,000 | -71.6% | 565,522 | -21.2% | 0.00% | 0.0% |
| Q4 2019 | $1,994,000 | +29.8% | 717,250 | -28.8% | 0.00% | 0.0% |
| Q3 2019 | $1,536,000 | -29.6% | 1,007,215 | -4.0% | 0.00% | -50.0% |
| Q2 2019 | $2,182,000 | -37.7% | 1,049,006 | +7.1% | 0.00% | -33.3% |
| Q1 2019 | $3,505,000 | -5.4% | 979,124 | +1.2% | 0.00% | -25.0% |
| Q4 2018 | $3,706,000 | -56.9% | 967,604 | +6.3% | 0.00% | -42.9% |
| Q3 2018 | $8,601,000 | +24.7% | 910,206 | -3.7% | 0.01% | +16.7% |
| Q2 2018 | $6,897,000 | +56.3% | 944,764 | +7.1% | 0.01% | +50.0% |
| Q1 2018 | $4,412,000 | +1.2% | 882,423 | +2.2% | 0.00% | 0.0% |
| Q4 2017 | $4,360,000 | -17.6% | 863,397 | +1.1% | 0.00% | -20.0% |
| Q3 2017 | $5,294,000 | +68.2% | 853,929 | -2.3% | 0.01% | +66.7% |
| Q2 2017 | $3,147,000 | +12.9% | 874,254 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $2,788,000 | +18.8% | 857,719 | -3.1% | 0.00% | +50.0% |
| Q4 2016 | $2,346,000 | -20.9% | 885,197 | +2.7% | 0.00% | -33.3% |
| Q3 2016 | $2,964,000 | +5.0% | 861,553 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $2,822,000 | -14.1% | 810,785 | +1.9% | 0.00% | -25.0% |
| Q1 2016 | $3,285,000 | -4.1% | 795,335 | +3.3% | 0.00% | 0.0% |
| Q4 2015 | $3,425,000 | – | 769,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |